Literature DB >> 25564611

Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Maxime Lecerf1, Tobias Scheel2, Anastas D Pashov3, Annaelle Jarossay1, Delphine Ohayon1, Cyril Planchais1, Stephane Mesnage4, Claudia Berek2, Srinivas V Kaveri1, Sébastien Lacroix-Desmazes1, Jordan D Dimitrov5.   

Abstract

The healthy immune repertoire contains a fraction of antibodies that bind to various biologically relevant cofactors, including heme. Interaction of heme with some antibodies results in induction of new antigen binding specificities and acquisition of binding polyreactivity. In vivo, extracellular heme is released as a result of hemolysis or tissue damage; hence the post-translational acquisition of novel antigen specificities might play an important role in the diversification of the immunoglobulin repertoire and host defense. Here, we demonstrate that seronegative immune repertoires contain antibodies that gain reactivity to HIV-1 gp120 upon exposure to heme. Furthermore, a panel of human recombinant antibodies was cloned from different B cell subpopulations, and the prevalence of antibodies with cofactor-induced specificity for gp120 was determined. Our data reveal that upon exposure to heme, ∼24% of antibodies acquired binding specificity for divergent strains of HIV-1 gp120. Sequence analyses reveal that heme-sensitive antibodies do not differ in their repertoire of variable region genes and in most of the molecular features of their antigen-binding sites from antibodies that do not change their antigen binding specificity. However, antibodies with cofactor-induced gp120 specificity possess significantly lower numbers of somatic mutations in their variable region genes. This study contributes to the understanding of the significance of cofactor-binding antibodies in immunoglobulin repertoires and of the influence that the tissue microenvironment might have in shaping adaptive immune responses.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antibody; Cloning; Cofactors; Heme; Human Immunodeficiency Virus (HIV); Immunoglobulin G (IgG); gp120

Mesh:

Substances:

Year:  2015        PMID: 25564611      PMCID: PMC4335253          DOI: 10.1074/jbc.M114.618124

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  [Post-translational diversification of immunoglobulins specificity].

Authors:  Cyril Planchais; Nimesh Gupta; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Med Sci (Paris)       Date:  2013-11-20       Impact factor: 0.818

2.  Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.

Authors:  H J Ditzel; K Itoh; D R Burton
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

3.  Novel unconventional binding site in the variable region of immunoglobulins.

Authors:  K Rajagopalan; G Pavlinkova; S Levy; P R Pokkuluri; M Schiffer; B E Haley; H Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Structural insights into the evolution of an antibody combining site.

Authors:  G J Wedemayer; P A Patten; L H Wang; P G Schultz; R C Stevens
Journal:  Science       Date:  1997-06-13       Impact factor: 47.728

5.  Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.

Authors:  A R Neurath; N Strick; A K Debnath
Journal:  J Mol Recognit       Date:  1995 Nov-Dec       Impact factor: 2.137

6.  Thermodynamic stability contributes to immunoglobulin specificity.

Authors:  Jordan D Dimitrov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Trends Biochem Sci       Date:  2014-03-28       Impact factor: 13.807

7.  Mutational analysis of 48G7 reveals that somatic hypermutation affects both antibody stability and binding affinity.

Authors:  Sophie B Sun; Shiladitya Sen; Nam-Jung Kim; Thomas J Magliery; Peter G Schultz; Feng Wang
Journal:  J Am Chem Soc       Date:  2013-06-26       Impact factor: 15.419

8.  Inhibition of human immunodeficiency virus-1 reverse transcriptase by heme and synthetic heme analogs.

Authors:  R Staudinger; N G Abraham; R D Levere; A Kappas
Journal:  Proc Assoc Am Physicians       Date:  1996-01

9.  Heme impairs the ball-and-chain inactivation of potassium channels.

Authors:  Nirakar Sahoo; Nishit Goradia; Oliver Ohlenschläger; Roland Schönherr; Manfred Friedrich; Winfried Plass; Reinhard Kappl; Toshinori Hoshi; Stefan H Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

10.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

View more
  8 in total

1.  Heme-Exposed Pooled Therapeutic IgG Improves Endotoxemia Survival.

Authors:  Iglika Djoumerska-Alexieva; Lubka T Roumenina; Tsvetanka Stefanova; Tchavdar Vassilev; Jordan D Dimitrov
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 2.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

3.  Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Authors:  Marie-Thérèse Hopp; Daniel Domingo-Fernández; Yojana Gadiya; Milena S Detzel; Regina Graf; Benjamin F Schmalohr; Alpha T Kodamullil; Diana Imhof; Martin Hofmann-Apitius
Journal:  Biomolecules       Date:  2021-04-27

4.  Aromatic Guanylhydrazones for the Control of Heme-Induced Antibody Polyreactivity.

Authors:  Nina Božinović; Vladimir Ajdačić; Jelena Lazic; Maxime Lecerf; Victoria Daventure; Jasmina Nikodinovic-Runic; Igor M Opsenica; Jordan D Dimitrov
Journal:  ACS Omega       Date:  2019-11-22

5.  Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities.

Authors:  Maxime Lecerf; Alexia Kanyavuz; Sofia Rossini; Jordan D Dimitrov
Journal:  Commun Biol       Date:  2021-03-23

6.  Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.

Authors:  Maxime Lecerf; Robin Lacombe; Alexia Kanyavuz; Jordan D Dimitrov
Journal:  Antibodies (Basel)       Date:  2022-02-02

7.  Is hemolysis a novel therapeutic target in COVID-19?

Authors:  Daiki Ousaka; Masahiro Nishibori
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

8.  Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody.

Authors:  Nimesh Gupta; Mélissanne de Wispelaere; Maxime Lecerf; Manjula Kalia; Tobias Scheel; Sudhanshu Vrati; Claudia Berek; Srinivas V Kaveri; Philippe Desprès; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.